Page last updated: 2024-10-31

midazolam and Amyotrophic Lateral Sclerosis

midazolam has been researched along with Amyotrophic Lateral Sclerosis in 3 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahao, A1
Meng, Y1
Llinas, M1
Huang, Y1
Hamani, C1
Mainprize, T1
Aubert, I1
Heyn, C1
Black, SE1
Hynynen, K1
Lipsman, N1
Zinman, L1
Oliver, DJ1
Campbell, C1
O'brien, T1
Sloan, R1
Sykes, N1
Tallon, C1
Taylor-Horan, J1
Udoma, M1
Kawa, C1
Stewart, J1
Hilden, K1
Adler, DG1
Tietze, C1
Bromberg, MB1
Fang, JC1

Trials

1 trial available for midazolam and Amyotrophic Lateral Sclerosis

ArticleYear
First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound.
    Nature communications, 2019, 09-26, Volume: 10, Issue:1

    Topics: Aged; Amyotrophic Lateral Sclerosis; Anesthetics, Intravenous; Blood-Brain Barrier; Brain; Drug Deli

2019

Other Studies

2 other studies available for midazolam and Amyotrophic Lateral Sclerosis

ArticleYear
Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, Volume: 11, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Analgesics, Opioid; Anti-Anxiety Agen

2010
A retrospective study of nurse-assisted propofol sedation in patients with amyotrophic lateral sclerosis undergoing percutaneous endoscopic gastrostomy.
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2012, Volume: 27, Issue:4

    Topics: Aged; Amyotrophic Lateral Sclerosis; Anesthesia; Conscious Sedation; Endoscopy; Female; Fentanyl; Ga

2012